These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Clinical Outcome
7 results:

  • 1. Estrogen concentration and estrogen receptor-β expression in postmenopausal colon cancer considering patient/tumor background.
    Honma N; Arai T; Matsuda Y; Fukunaga Y; Akishima-Fukasawa Y; Yamamoto N; Kawachi H; Ishikawa Y; Takeuchi K; Mikami T
    J Cancer Res Clin Oncol; 2022 May; 148(5):1063-1071. PubMed ID: 35032217
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MicroRNA let-7, T Cells, and Patient Survival in colorectal cancer.
    Dou R; Nishihara R; Cao Y; Hamada T; Mima K; Masuda A; Masugi Y; Shi Y; Gu M; Li W; da Silva A; Nosho K; Zhang X; Meyerhardt JA; Giovannucci EL; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Cancer Immunol Res; 2016 Nov; 4(11):927-935. PubMed ID: 27737877
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment.
    Malara N; Trunzo V; Foresta U; Amodio N; De Vitis S; Roveda L; Fava M; Coluccio M; Macrì R; Di Vito A; Costa N; Mignogna C; Britti D; Palma E; Mollace V
    J Transl Med; 2016 May; 14(1):133. PubMed ID: 27176720
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer.
    Meshcheryakova A; Tamandl D; Bajna E; Stift J; Mittlboeck M; Svoboda M; Heiden D; Stremitzer S; Jensen-Jarolim E; Grünberger T; Bergmann M; Mechtcheriakova D
    PLoS One; 2014; 9(6):e99008. PubMed ID: 24905750
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
    Malka D; Boige V; Jacques N; Vimond N; Adenis A; Boucher E; Pierga JY; Conroy T; Chauffert B; François E; Guichard P; Galais MP; Cvitkovic F; Ducreux M; Farace F
    Ann Oncol; 2012 Apr; 23(4):919-27. PubMed ID: 21825101
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
    Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
    J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.